作者
Maria A Potenza, Flora L Marasciulo, Mariela Tarquinio, Edy Tiravanti, Giuseppe Colantuono, Antonio Federici, Jeong-a Kim, Michael J Quon, Monica Montagnani
发表日期
2007/5
期刊
American Journal of Physiology-Endocrinology and Metabolism
卷号
292
期号
5
页码范围
E1378-E1387
出版商
American Physiological Society
简介
Epigallocatechin gallate (EGCG), a bioactive polyphenol in green tea, may augment metabolic and vascular actions of insulin. Therefore, we investigated effects of EGCG treatment to simultaneously improve cardiovascular and metabolic function in spontaneously hypertensive rats (SHR; model of metabolic syndrome with hypertension, insulin resistance, and overweight). In acute studies, EGCG (1–100 μM) elicited dose-dependent vasodilation in mesenteric vascular beds (MVB) isolated from SHR ex vivo that was inhibitable by Nω-nitro-l-arginine methyl ester (l-NAME; nitric oxide synthase antagonist) or wortmannin [phosphatidylinositol (PI) 3-kinase inhibitor]. In chronic studies, 9-wk-old SHR were treated by gavage for 3 wk with EGCG (200 mg·kg−1·day−1), enalapril (30 mg·kg−1·day−1), or vehicle. A separate group of SHR receiving l-NAME (80 mg/l in drinking water) was treated for 3 wk with either EGCG or …
引用总数
20072008200920102011201220132014201520162017201820192020202120222023202412242730344242292740282033221624134